According to a large study published in The BMJ , adults with type 2 diabetes who started GLP-1 receptor agonists were more likely to develop alopecia than those taking SGLT-2 inhibitors or DPP-4 inhibitors (1 Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation Go to source) Trusted Source Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation Go to source)
But with over-the-counter products that use glycolic acid, it may take several months of consistent use before you notice your skin looks brighter or your pigmentation is more even. Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more
Convenience Topical products fit easily into a daily routine
Other players like AstraZeneca and Sanofi likewise report extensive machine learning in their pipelines
Your prescribing provider will assess your individual health history and medications before starting compounded semaglutide or tirzepatide
Behind these figures are real stories and real weight-loss struggles